These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19674447)

  • 1. Persistence of colicinogenic Escherichia coli in the mouse gastrointestinal tract.
    Gillor O; Giladi I; Riley MA
    BMC Microbiol; 2009 Aug; 9():165. PubMed ID: 19674447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteriocin synthesis in uropathogenic and commensal Escherichia coli: colicin E1 is a potential virulence factor.
    Smajs D; Micenková L; Smarda J; Vrba M; Sevčíková A; Vališová Z; Woznicová V
    BMC Microbiol; 2010 Nov; 10():288. PubMed ID: 21078157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal changes in the frequency of colicinogeny in Escherichia coli from house mice.
    Gordon DM; Riley MA; Pinou T
    Microbiology (Reading); 1998 Aug; 144 ( Pt 8)():2233-2240. PubMed ID: 9720045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of resistance to colicinogenic Escherichia coli by E. coli O157:H7 strains.
    Schamberger GP; Diez-Gonzalez F
    J Appl Microbiol; 2005; 98(1):245-52. PubMed ID: 15610438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Frequency of colicin and hemolysins in Escherichia coli isolated from pregnant patients with urinary tract infection, symptomatic and asymptomatic].
    Arriaga-Alba M; Rivera Sánchez R; Romero Díaz G; Hernando Aguilar N; García Jiménez E; Flores Paz R
    Ginecol Obstet Mex; 2000 Jul; 68():275-81. PubMed ID: 11006640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-antibiotic antibacterial peptides and proteins of
    Bosák J; Hrala M; Micenková L; Šmajs D
    Expert Rev Anti Infect Ther; 2021 Mar; 19(3):309-322. PubMed ID: 32856960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colicins prevent colonization of urinary catheters.
    Trautner BW; Hull RA; Darouiche RO
    J Antimicrob Chemother; 2005 Aug; 56(2):413-5. PubMed ID: 15980093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Porcine pathogenic Escherichia coli strains differ from human fecal strains in occurrence of bacteriocin types.
    Bosák J; Hrala M; Pirková V; Micenková L; Čížek A; Smola J; Kučerová D; Vacková Z; Budinská E; Koláčková I; Šmajs D
    Vet Microbiol; 2019 May; 232():121-127. PubMed ID: 31030835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriocinogeny in experimental pigs treated with indomethacin and Escherichia coli Nissle.
    Bures J; Smajs D; Kvetina J; Förstl M; Smarda J; Kohoutova D; Kunes M; Cyrany J; Tacheci I; Rejchrt S; Lesna J; Vorisek V; Kopacova M
    World J Gastroenterol; 2011 Feb; 17(5):609-17. PubMed ID: 21350709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriocin-Producing
    Kuznetsova MV; Mihailovskaya VS; Remezovskaya NB; Starčič Erjavec M
    Microorganisms; 2022 Aug; 10(8):. PubMed ID: 36013976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colicinogenicity and enteropathogenicity of Escherichia coli associated with gastroenteritis in man.
    Chakraborty D; Nag NC
    J Commun Dis; 1998 Dec; 30(4):263-5. PubMed ID: 10810567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid invasion by colicinogenic Escherichia coli with novel immunity functions.
    Tan Y; Riley MA
    Microbiology (Reading); 1996 Aug; 142 ( Pt 8)():2175-80. PubMed ID: 8760932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escherichia coli bacteriocins: antimicrobial efficacy and prevalence among isolates from patients with bacteraemia.
    Budič M; Rijavec M; Petkovšek Z; Zgur-Bertok D
    PLoS One; 2011; 6(12):e28769. PubMed ID: 22205967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colicin V38 and microcin C38 produced by Escherichia coli strain 38.
    Leavitt RW; Braithwaite C; Jensen MM
    Avian Dis; 1997; 41(3):568-77. PubMed ID: 9356701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microcin determinants are associated with B2 phylogroup of human fecal Escherichia coli isolates.
    Micenková L; Bosák J; Štaudová B; Kohoutová D; Čejková D; Woznicová V; Vrba M; Ševčíková A; Bureš J; Šmajs D
    Microbiologyopen; 2016 Jun; 5(3):490-8. PubMed ID: 26987297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteriocin diversity and the frequency of multiple bacteriocin production in Escherichia coli.
    Gordon DM; O'Brien CL
    Microbiology (Reading); 2006 Nov; 152(Pt 11):3239-3244. PubMed ID: 17074895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential of bacteriocin-producing probiotics and associated caveats.
    Gordon DM
    Future Microbiol; 2009 Oct; 4(8):941-3. PubMed ID: 19824784
    [No Abstract]   [Full Text] [Related]  

  • 18. Host gastro-intestinal dynamics and the frequency of colicin production by Escherichia coli.
    Barnes B; Sidhu H; Gordon DM
    Microbiology (Reading); 2007 Sep; 153(Pt 9):2823-2827. PubMed ID: 17768227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colicin insensitivity correlates with a higher prevalence of extraintestinal virulence factors among Escherichia coli isolates from skin and soft-tissue infections.
    Petkovšek Ž; Žgur-Bertok D; Starčič Erjavec M
    J Med Microbiol; 2012 Jun; 61(Pt 6):762-765. PubMed ID: 22403139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of colicin V in vitro and in vivo and observations on its effects in experimental animals.
    Ozanne G; Mathieu LG; Baril JP
    Infect Immun; 1977 Sep; 17(3):497-503. PubMed ID: 332624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.